›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:Tempus xG
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
TempusType:
Laboratory Developed Test
Related tests:
Tempus xG is a 52-gene panel germline sequencing assay that specifically identifies genetic variants associated with hereditary cancer syndromes and inherited risk of cancer. xG is designed for oncologists seeking to assess their patients’ hereditary risk of cancer by reporting clinically actionable, germline variants in genes such as BRCA1/2 and the Lynch syndrome genes.
Cancer:
Brain Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Ovarian Cancer, Pancreatic Cancer, Renal Cell Carcinoma, Thyroid Gland Carcinoma
Gene:
BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset)
BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset)
Method:
Next-Generation Sequencing (NGS)
